UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

LGL Clonal Expansion and Unexplained Cytopenia: Two Clues Don’t Make an Evidence

Cancers, 2022-10, Vol.14 (21), p.5236

2022

Link zum Volltext

Verfügbarkeit prüfen

Autoimmune Cytopenias and Dysregulated Immunophenotype Act as Warning Signs of Inborn Errors of Immunity: Results From a Prospective Study

Frontiers in immunology, 2022-01, Vol.12, p.790455-790455

2022

Link zum Volltext

Verfügbarkeit prüfen

FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-t Cells

Mediterranean journal of hematology and infectious diseases, 2024, Vol.16 (1), p.e2024029-e2024029

2024

Link zum Volltext

Verfügbarkeit prüfen

Phenotypical T Cell Differentiation Analysis: A Diagnostic and Predictive Tool in the Study of Primary Immunodeficiencies

Frontiers in immunology, 2019-11, Vol.10, p.2735-2735

2019

Link zum Volltext

Verfügbarkeit prüfen

NATURAL HISTORY OF RALD: A 20 YEAR FOLLOW-UP OF A NRAS MUTATED PATIENT EXCLUDING A MALIGNANT PROGRESSION

EJC paediatric oncology, 2023-12, Vol.2, p.100104, Article 100104

2023

Link zum Volltext

Verfügbarkeit prüfen

P499: APPLICABILITY OF 2022 CLASSIFICATIONS OF ACUTE MYELOID LEUKEMIA IN THE REAL‐WORLD SETTING

HemaSphere, 2023-08, Vol.7 (S3), p.e5402602-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

P478: MOLECULAR CHARACTERIZATION OF EXTRAMEDULLARY LOCALIZATIONS IN ACUTE MYELOID LEUKEMIA (AML)

HemaSphere, 2023-08, Vol.7 (S3), p.e9215641-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Clonal hematopoiesis in children with predisposing conditions

Seminars in hematology, 2024-02, Vol.61 (1), p.35-42

2024

Link zum Volltext

Verfügbarkeit prüfen

The Combination of Decitabine Plus Venetoclax Is an Active Salvage Therapy for AML Post HR-MDS Progressed during Treatment with Azacitidine Based Regimens

Blood, 2022-11, Vol.140 (Supplement 1), p.11738-11739

2022

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic Stem Cell Transplant for Myelodysplastic Syndrome in the New Molecular Era of IPSS-M

Blood, 2022-11, Vol.140 (Supplement 1), p.10616-10617

2022

Link zum Volltext

Verfügbarkeit prüfen

PIEZO1 Mutation May Determine Early Onset of Clinical Manifestation of Anemia of Myelodysplastic Syndromes

Blood, 2021-11, Vol.138 (Supplement 1), p.1528-1528

2021

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and Distribution of Erythroid Progenitors and Precursors Correlate with Erythropoiesis Stimulating Agents (ESAs) Response in Lower Risk Myelodysplastic Syndromes

Blood, 2022-11, Vol.140 (Supplement 1), p.9777-9778

2022

Link zum Volltext

Verfügbarkeit prüfen

Outcome prediction in myelodysplastic neoplasm undergoing hematopoietic cell transplant in the molecular era of IPSS-M

Leukemia, 2023-03, Vol.37 (3), p.717-719

2023

Link zum Volltext

Verfügbarkeit prüfen

Ninety-Minute Daratumumab Infusions for Relapsed and Refractory Multiple Myeloma: Two Years of Italian Single-Center Observational Study

Clinical lymphoma, myeloma and leukemia, 2021-11, Vol.21 (11), p.e850-e852

2021

Link zum Volltext

Verfügbarkeit prüfen

The case of an APDS patient: Defects in maturation and function and decreased in vitro anti-mycobacterial activity in the myeloid compartment

Clinical immunology (Orlando, Fla.), 2017-05, Vol.178, p.20-28

2017

Link zum Volltext

Verfügbarkeit prüfen

PIEZO1 mutations impact on early clinical manifestations of myelodysplastic syndromes

American journal of hematology, 2023-04, Vol.98 (4), p.E72-E75

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical, Immunological, and Molecular Features of Typical and Atypical Severe Combined Immunodeficiency: Report of the Italian Primary Immunodeficiency Network

Frontiers in immunology, 2019-08, Vol.10, p.1908-1908

2019

Link zum Volltext

Verfügbarkeit prüfen

Safety of rapid daratumumab infusion in relapsed and refractory multiple myeloma

Clinical lymphoma, myeloma and leukemia, 2019-10, Vol.19 (10), p.e141-e141

2019

Link zum Volltext

Verfügbarkeit prüfen

Outcome of MDS, MDS/MPN Patients Aged <65 Treated with Hypomethylating Agents as a Bridge to Transplant in a Single Tertiary-Care Italian Center

Clinical lymphoma, myeloma and leukemia, 2019-09, Vol.19, p.S346-S346

2019

Link zum Volltext

Verfügbarkeit prüfen

Poster: MDS-223: Response to Erythroid Stimulating Agents (ESA) and Flow Cytometric Characteristics of Bone Marrow Erythroid Precursors in IPSS-R Lower-Risk Myelodysplastic Syndrome Patients

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S228-S228

2021

Link zum Volltext

Verfügbarkeit prüfen

MDS-223: Response to Erythroid Stimulating Agents (ESA) and Flow Cytometric Characteristics of Bone Marrow Erythroid Precursors in IPSS-R Lower-Risk Myelodysplastic Syndrome Patients

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S344-S344

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical and Genetic Profiles of Young Adult Patients with Myelodysplastic Syndromes

Clinical lymphoma, myeloma and leukemia, 2019-09, Vol.19, p.S347-S347

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(32)

Publikationsform

Sprache

Englisch
(33)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(11)
Science & Technology
(11)
Humans
(7)
Immunology
(7)
Hematology
(5)
Mutation
(4)
Oncology
(4)
Primary Immunodeficiencies
(4)
Diagnosis
(3)
Male
(3)
Next Generation Sequencing
(3)
Adolescent
(2)
Adult
(2)
Aged
(2)
Bone Marrow
(2)
Child
(2)
Class I Phosphatidylinositol 3-Kinases - Genetics
(2)
Class I Phosphatidylinositol 3-Kinases - Immunology
(2)
Cytogenetics
(2)
Cytotoxicity
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

LGL Clonal Expansion and Unexplained Cytopenia: Two Clues Don’t Make an Evidence

Autoimmune Cytopenias and Dysregulated Immunophenotype Act as Warning Signs of Inborn Errors of Immunity: Results From a Prospective Study

FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-t Cells

Phenotypical T Cell Differentiation Analysis: A Diagnostic and Predictive Tool in the Study of Primary Immunodeficiencies

NATURAL HISTORY OF RALD: A 20 YEAR FOLLOW-UP OF A NRAS MUTATED PATIENT EXCLUDING A MALIGNANT PROGRESSION

P499: APPLICABILITY OF 2022 CLASSIFICATIONS OF ACUTE MYELOID LEUKEMIA IN THE REAL‐WORLD SETTING

P478: MOLECULAR CHARACTERIZATION OF EXTRAMEDULLARY LOCALIZATIONS IN ACUTE MYELOID LEUKEMIA (AML)

Clonal hematopoiesis in children with predisposing conditions

The Combination of Decitabine Plus Venetoclax Is an Active Salvage Therapy for AML Post HR-MDS Progressed during Treatment with Azacitidine Based Regimens

Allogeneic Stem Cell Transplant for Myelodysplastic Syndrome in the New Molecular Era of IPSS-M

PIEZO1 Mutation May Determine Early Onset of Clinical Manifestation of Anemia of Myelodysplastic Syndromes

Characteristics and Distribution of Erythroid Progenitors and Precursors Correlate with Erythropoiesis Stimulating Agents (ESAs) Response in Lower Risk Myelodysplastic Syndromes

Outcome prediction in myelodysplastic neoplasm undergoing hematopoietic cell transplant in the molecular era of IPSS-M

Hypocellular myelodysplastic syndromes (h-MDS): from clinical description to immunological characterization in the Italian multi-center experience

Ninety-Minute Daratumumab Infusions for Relapsed and Refractory Multiple Myeloma: Two Years of Italian Single-Center Observational Study

The case of an APDS patient: Defects in maturation and function and decreased in vitro anti-mycobacterial activity in the myeloid compartment

PIEZO1 mutations impact on early clinical manifestations of myelodysplastic syndromes

Clinical, Immunological, and Molecular Features of Typical and Atypical Severe Combined Immunodeficiency: Report of the Italian Primary Immunodeficiency Network

Safety of rapid daratumumab infusion in relapsed and refractory multiple myeloma

Outcome of MDS, MDS/MPN Patients Aged <65 Treated with Hypomethylating Agents as a Bridge to Transplant in a Single Tertiary-Care Italian Center

Poster: MDS-223: Response to Erythroid Stimulating Agents (ESA) and Flow Cytometric Characteristics of Bone Marrow Erythroid Precursors in IPSS-R Lower-Risk Myelodysplastic Syndrome Patients

MDS-223: Response to Erythroid Stimulating Agents (ESA) and Flow Cytometric Characteristics of Bone Marrow Erythroid Precursors in IPSS-R Lower-Risk Myelodysplastic Syndrome Patients

AML-396 Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Initial Results of a Novel, Ongoing BPDCN International Registry Program

POSTER: AML-396 Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Initial Results of a Novel, Ongoing BPDCN International Registry Program

Clinical and Genetic Profiles of Young Adult Patients with Myelodysplastic Syndromes

Suchergebnisse filtern